TRDA
Entrada Therapeutics, Inc. · Healthcare
CFO Kory James Wentworth sold $50K of Entrada Therapeutics, Inc.
Sold$50,285
$12.31Price
4,086Shares
−5%Stake
What TRDA did after the filing
- The stock from Fri, Mar 8 close, $12.68
- +3.3%
- S&P 500, same days
- −2.0%
Measured over 30 trading days, to the Apr 22 close.
Traded Wed, Mar 6. Filed Fri, Mar 8, 11:36 AM ET, during the session. Returns use the Mar 8 close and the Apr 22 close. Not investment advice.